Characteristics of anticoagulant therapy and comorbidity related to overanticoagulation

Thrombosis and Haemostasis

Volumn 86, Issue 2, 2001, Pages 569-574

  Penning Van Beest, F J A ^a   Van Meegen, E ^a   Rosendaal, F R ^a   Stricker, B H Ch ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Characteristics of therapy; Comorbidity; Coumarin anticoagulants; Incidence; Overanticoagulation

Indexed keywords

ACENOCOUMAROL; COUMARIN ANTICOAGULANT; PHENPROCOUMON;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING DISORDER; CASE CONTROL STUDY; CLINICAL TRIAL; COHORT ANALYSIS; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; FEMALE; FEVER; HEART DISEASE; HIGH RISK POPULATION; HUMAN; INCIDENCE; INTERNATIONAL STANDARD UNIT; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; THROMBOEMBOLISM;

EID: 0034908623     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1616088     Document Type: Article

References (28)

1. Guidelines on oral anticoagulation: Third edition
2. Structure and mechanism of activation of vitamin K antagonists
3. Optimal oral anticoagulant therapy in patients with mechanical heart valves
4. Anticoagulant-related bleeding: Clinical epidemiology, prediction, and prevention
5. Assessment of a bleeding risk index in two cohorts of patients treated with oral anticoagulants
6. Bleeding complications of oral anticoagulant treatment: An inception-cohort, prospective collaborative study (ISCOAT). Italian study on Complications of Oral Anticoagulant Therapy
7. Oral anticoagulants: Mechanism of action, clinical effectiveness, and optimal therapeutic range
8. Determinants of the response to oral anticoagulant drugs in man
9. Drugs affecting blood clotting, fibrinolysis, and hemostasis
10. Bleeding complications from warfarin anticoagulation in patients with malignancy
11. A comparative study concerning the stability of the anticoagulant effect of acenocoumarol and phenprocoumon
12. 4-Hydroxycoumarin oral anticoagulants: Pharmacokinetics-response relationship
13. The role of compliance as a cause of instability in oral anticoagulant therapy
14. Poor compliance is a major factor in unstable outpatient control of anticoagulant therapy
15. Therapeutic control of oral anticoagulant treatment in The Netherlands
16. Anticoagulant control in The Netherlands
17. Optimal therapeutic anticoagulation
18. Laboratory control, optimal therapeutic ranges and therapeutic quality control in oral anticoagulation
19. Clinically important drug interactions with anticoagulants. An update
20. Effect of weight loss on coagulation factors VII and X
21. Anticoagulation instability with life-threatening complication after dietary modification
22. Association of fibrinogen and coagulation factors VII and VIII with cardiovascular risk factors in the elderly: The Cardiovascular Health Study. Cardiovascular Health Study Investigators
23. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors
24. Dietary modification as cause of anticoagulation instability
25. Analysis of risk factors for over-anticoagulation in patients receiving long-term warfarin
26. Audit of the frequency and clinical response to excessive oral anticoagulation in an out-patient population
27. Acetaminophen and other risk factors for excessive warfarin anticoagulation